Perceptive

CROs/Service Providers

Siro Clinpharm relocates corporate offices

Wednesday, February 18, 2015 11:48 AM

SIRO Clinpharm, an India-based CRO, has relocated its corporate headquarters within Mumbai, India. The move allows SIRO to consolidate its position in the Indian healthcare development space.

More... »

Theorem Clinical Research

Molecular Response sells business unit to Crown Bioscience

Thursday, February 12, 2015 03:00 PM

Molecular Response (MRL), a privately held molecular diagnostic services company based in San Diego, Calif., has sold its PDX business unit to Crown Bioscience, a drug discovery and development service company headquartered in Santa Clara, Calif.

More... »

Quest Diagnostics

Inventiv Health to open new clinic in Miami

Thursday, February 12, 2015 01:13 PM

inVentiv Health, a Princeton, N.J.-based provider of clinical development and commercialization services, will open a new phase I/IIA clinic in Miami, expanding its phase I clinical services to the U.S.

More... »

Biorasi adds endocrinology division, to hire 30

Thursday, February 12, 2015 01:02 PM

Biorasi, a full-service CRO powered by ProAct+, has formed an endocrinology division established to consolidate and expand Biorasi market leadership in running clinical trials in diabetes and women’s health. The new division will be led by Bill Doyle, the division manager, out of the Miami, Fla. headquarters.

More... »

BioPharma Services, Scentryphar partner

Wednesday, February 11, 2015 12:30 PM

BioPharma Services (BPSI) has entered into a partnership and joint venture agreement with Scentryphar, a CRO located in Sao Paulo, Brazil. The partnership will support local and global sponsors looking to bring generic and innovative drugs to the Brazilian market by offering one-stop shopping and joint experience in clinical conduct, bioanalysis, data management, statistics and scientific and medical writing.

More... »

Water Street invests in generic injectable drug services company Custopharm

Wednesday, February 4, 2015 01:32 PM

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry headquartered in Chicago, has invested in Custopharm, a generic injectable drug services company. Water Street's team has committed equity to both acquire and expand the Carlsbad, Calif.-based company. The healthcare firm has recruited William Larkins, Ph.D., former vice president and general manager of Bedford Laboratories, as CEO of Custopharm.

More... »

CSSi LifeSciences introduces SmartStudy Design and Feasibility

Wednesday, February 4, 2015 01:25 PM

CSSi LifeSciences, a Glen Burnie, Md.-based provider of fully integrated solutions that span the lifecycle of a new drug or device, has launched its newest product offering in its portfolio of services—SmartStudy Design and Feasibility. CSSi LifeSciences is a partner company of global patient recruitment solutions provider CSSi.

More... »

ChemPartner opens San Francisco research facility

Wednesday, February 4, 2015 01:22 PM

ChemPartner, the service division of the Shanghai, China-based ShangPharma group, recently expanded its global footprint with the establishment of a 24,000-square-foot research facility in South San Francisco.

More... »

Campbell Alliance forms suite of services for product launches

Monday, February 2, 2015 03:02 PM

Campbell Alliance, the consulting arm of inVentiv Health, has formed the Campbell Alliance Launch Suite, an integrated offering designed to bring products to market primed for success.

More... »

Icon to acquire MediMedia Pharma Solutions for $120M

Monday, February 2, 2015 01:54 PM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions, to acquire MediMedia Pharma Solutions for a cash consideration of $120 million. MediMedia Pharma Solutions is division of MediMedia USA and is owned by Vestar Capital Partners.

More... »


CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs